PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity-Reference-Cited by-同舟云学术

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity

Published:2018-05-21 Issue:7 Volume:128 Page:2787-2801
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Daenthanasanmak Anusara,Wu Yongxia,Iamsawat Supinya,Nguyen Hung D.,Bastian David,Zhang MengMeng,Sofi M. Hanief,Chatterjee Shilpak,Hill Elizabeth G.,Mehrotra Shikhar,Kraft Andrew S.,Yu Xue-Zhong

Funder

NIH Clinical Center

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/95407/files/pdf

Reference66 articles.

1. PIM kinase (and Akt) biology and signaling in tumors

2. Pim kinases in hematological malignancies: where are we now and where are we going?;Mondello;J Hematol Oncol,2014

3. The human Pim-2 proto-oncogene and its testicular expression;Baytel;Biochim Biophys Acta,1998

4. The PIM Family of Serine/Threonine Kinases in Cancer

5. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of Pim-1 kinases in inflammatory signaling pathways;Inflammation Research;2024-07-30

2. A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma;Signal Transduction and Targeted Therapy;2024-04-20

3. PIM kinase inhibitor AZD1208 in conjunction with Th1 cytokines potentiate death of breast cancer cells in vitro while also maximizing suppression of tumor growth in vivo when combined with immunotherapy;Cellular Immunology;2024-03

4. PIM kinases regulate early human Th17 cell differentiation;Cell Reports;2023-12

5. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome;Biomedicine & Pharmacotherapy;2023-09